Pharma CEO: US unemployment 'worrisome'

Eli Lilly chief executive John Lechleiter tells Andrew Jack, the FT's pharmaceutical correspondent, that US unemployment levels are 'worrisome' and that drugs companies have to reach out to academics and biotech start-ups in order to innovate.